The divisional application of the invention provides torasemide with a novel crystal form and with an application number of 201610363797.0, and discloses a torasemide tablet. The torasemide tablet is a preparation mainly prepared from the torasemide with the novel crystal form. According to the crystal form, the aspects of the stability, dissolution rate, water solubility and the like of the preparation are greatly improved. The torasemide tablet can play a role of slow release without a retardant, so that the use of the retardant is reduced, toxic and side effects are reduced, and the preparation is very applicable to clinical application. According to the torasemide tablet, the zero-level release, smooth dissolution and stable decompression are realized, the awkwardness of urgent urination of a patient is avoided, the toxic and side effects are reduced, and the torasemide tablet can be adequately absorbed after being orally taken. The torasemide tablet is good in stability and medication compliance, simple in production process, relatively low in cost and easy to industrialize.